市場調查報告書

輸液療法的全球市場:輸液手法·輸液類別·各用途·各地區的未來預測

Fluid Therapy Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 850084
出版日期 內容資訊 英文 106 Pages
商品交期: 2-3個工作天內
價格
輸液療法的全球市場:輸液手法·輸液類別·各用途·各地區的未來預測 Fluid Therapy Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 106 Pages
簡介

本報告提供全球輸液療法的市場相關分析,提供整體市場結構和背景情況,主要的推動及阻礙市場要素,加入市場的方法與難易度,各輸液手法·輸液類別·各用途·各地區的市場趨勢預測 (今後7年份),市場競爭結構,近來的資本交易·策略展開的動向,主要企業的簡介等相關調查。

第1章 輸液療法:市場概要

第2章 輸液療法市場:摘要整理

第3章 輸液療法市場

  • 比較分析
    • 產品的互相比較:前十大企業的情況
    • 前五名公司的財務分析
    • 市場規模的明細 (以金額為準):前十大企業的情況
    • 專利分析:前十大企業的情況
    • 價格趨勢分析

第4章 輸液療法市場:Start-Ups企業方案

  • Start-Ups企業 (前十大企業)的分析
    • 投資額
    • 市場收益額
    • 市場佔有率
    • 市場規模·用途分析
    • 創業投資與資金籌措方案

第5章 輸液療法市場:產業的市場進入方案

  • 管理體制:概要
  • 新商務和「企業發展的難易度指標」(Ease of Doing business index)
  • 案例研究:成功的創投公司
  • 客戶分析:前十大企業的情況

第6章 輸液療法市場影響要素

  • 市場促進因素
  • 市場阻礙因素·課題
  • 波特的五力分析

第7章 輸液療法市場:策略分析

  • 價值鏈分析
  • 市場機會分析
  • 產品生命週期
  • 供應商/經銷商的市場佔有率

第8章 輸液療法市場:各治療法

  • 簡介
  • 人用
    • 維持療法
    • 輸液甦醒

第9章 各輸液療法市場:輸液手法

  • 簡介
  • 人用
    • 口服輸液
    • 皮下輸液
    • 靜脈內輸液
    • 骨髓內輸液
  • 動物用
    • 口服輸液
    • 皮下輸液
    • 腹腔內輸液
    • 靜脈內輸液
    • 骨髓內輸液
    • 其他

第10章 輸液療法市場:輸液類別

  • 簡介
  • 人用
    • 膠體
    • 晶體液
      • 等滲透壓
      • 低滲透壓
      • 高滲透壓
    • 血液·血液製劑
  • 動物用
    • 膠體
      • 天然
      • 合成
    • 晶體液
      • 等滲透壓
      • 低滲透壓
      • 高滲透壓

第11章 輸液療法市場:各用途

  • 簡介
  • 人用
    • 麻醉
    • 心肺甦醒 (CPR)
    • 鬱血性心衰竭 (CHF)
    • 輸液
    • 高滲食鹽水
    • 其他
  • 動物用
    • 麻醉
    • 貧血症
    • 腹瀉
    • 低血容量
    • 心臟疾病
    • 其他

第12章 輸液療法市場:各地區

  • 簡介
  • 北美市場
    • 美國,加拿大,墨西哥等
  • 南美市場
    • 巴西,委內瑞拉,阿根廷,厄瓜多,秘魯,哥倫比亞,哥斯大黎加等
  • 歐洲市場
    • 法國,丹麥,德國,西班牙,比利時,英國,義大利,荷蘭等
  • 亞太地區市場
    • 中國,印度,日本,韓國,澳洲·紐西蘭,台灣,馬來西亞等
  • 其他的國家的市場 (RoW:中東·非洲)

第13章 輸液療法市場:市場變化的方向性

  • 新產品的銷售
  • 企業合併·收購 (M&A),事業合作·聯盟,合資企業 (JV)

第14章 輸液療法市場:各產業/各領域的競爭情形

  • 市場佔有率分析
    • 各國市場佔有率:大企業的情況
    • 各地區的市場佔有率:前十大企業的情況
    • 各用途的市場佔有率:前十大企業的情況
    • 各產品/產品類型的市場佔有率:前十大企業的情況
    • 全球整體的市場佔有率:前十大企業的情況
    • 各種對企業而言的最佳業務實踐

第15章 主要企業一覽:各國

第16章 企業分析

  • 市場佔有率,企業收益額,主要產品,企業合併·收購 (M&A),近幾年趨勢
  • Baxter International, Inc. (美國)
  • B. Braun Melsungen AG (德國)
  • Fresenius Kabi AG (德國)
  • Dechra Veterinary Products, LLC (美國)
  • D.J. Laboratories Pvt. Ltd (印度)
  • Animalcare Ltd. (英國)
  • ICU Medical (美國)
  • 其他

第17章 附錄

第18章 分析方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 1264

Fluid Therapy Market Overview

Fluid therapy is involves infusing crystalloid solutions into patients who are hypovolemic, or in cases of dehydration to replace ongoing fluid losses and meet the fluid requirements of patients who cannot take fluids orally. The Fluid Therapy market has been segmented on the basis of therapy type, routes of fluid administration, types of fluids, by application, and by geographic regions.

Different types of fluids such as colloidal solutions, crystalloid solutions, and blood products are used during fluid therapy. Administration of these fluids is done by using different routes such as oral, subcutaneous, intravenous, intraosseous, and so on. The fluid therapy market generated revenue of $7,297m in 2017 and is estimated to exceed $10,559m by 2023, growing at an estimated CAGR of 6.4%.

Fluid Therapy Market Outlook

The global Fluid Therapy market has been witnessing a brisk growth in the recent years owing to increased incidences of chronic diseases related to nephrology, gastrointestinal tract, heart failures, cancer and diabetes. Fluid therapy is used to treat disorders such as sepsis, colic, hypovolemia and shock. Innovative products and services can help physicians and doctors protect both humans and animals from such diseases. The human segment accounted for 78% of the total market share in 2017.

Colloids and crystalloids are the types of fluids uses in fluid therapy to maintain or restore the vascular volume and tissue perfusion in humans and animals. In humans, at times, blood and blood products are also intravenously administered to restore circulation to vital organs following loss of intravascular volume due to bleeding, plasma loss, and so on. North America dominated the Fluid Therapy Market with 33% of the overall market revenue in 2017. The Asia-Pacific region forecast to be the fastest growing market for fluid therapy. The region's market is estimated to grow at a CAGR of 7.4% during the forecast period 2018-2023.

Fluid Therapy Market Growth Drivers

Increased awareness among people about fitness and health issues and their urge to take preventive steps to avoid chronic diseases are the major factors driving the market for fluid therapy. The rise in demand for maintenance therapy using colloids and crystalloids is also boosting the market for fluid therapy. Due to rapid urbanization, and sedentary lifestyle of people, there has been an exponential rise in chronic diseases such as cancer, diabetes, CVDs, arthritis, COPD, and diabetes. Thus, the demand for intravenous fluid therapy is increasing rapidly.

Fluid Therapy Market Challenges

Plastic contaminants have been found in blood products stored for long periods in bags. Frequent use of such solvable plastics in high doses can harm patients and research laboratory animals. Plastic bags can leach toxic chemicals into patients' veins. So, this is a major constraint for the fluid therapy market.

Strigent regulations regarding the approvals of medical devices use in fluid therapy and high costs associated with the treatment are hindering the growth of fluid therapy market

Fluid Therapy Market Research Scope

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the fluid therapy market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of fluid therapy and fluids, and their specific applications.

Fluid Therapy Market Report: Industry Coverage

Fluid Therapy Market - By Therapy: Maintenance Therapy and Fluid Resuscitation

Fluid Therapy Market - By Routes of Fluid Administration: Oral, Subcutaneous, Intravenous, Intraosseous, Intraperitoneal and Others

Fluid Therapy Market - By Types of Fluids: Colloids, Crystalloids, Blood & Blood Products and Others

Fluid Therapy Market - By Application: Human and Animals

The Fluid Therapy market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia & New Zealand, South Korea, India, Taiwan, Malaysia

Middle East and Africa: Israel, South Africa, Saudi Arabia

Fluid Therapy Market Key Players

Some of the key players mentioned in this market research report include Baxter International, Inc. (the U.S.), B. Braun Melsungen AG (Germany) Fresenius Kabi AG (Germany), Dechra Veterinary Products, LLC (the U.S.), D.J. Laboratories Pvt. Ltd (India), Animalcare Ltd. (the U.K.), and ICU Medical (the U.S.).

Fluid Therapy Market Trends

Patient's fast recovery owing to fluid therapy is providing opportunities to the market players to manufacture innovative products, which drives the market growth.

The global market for fluid therapy is well established and its growth can be accredited to the growing health awareness and an increase in chronic diseases in the past few years.

North America dominated the fluid therapy market with a share of 33% of the total market value in 2017. The market in North America was valued at $2,386 m in 2017 and is estimated to reach $3,516m by 2023.

Innovative fluid therapy products are more helpful to nurses in case of treatment, thus providing manufacturers an opportunity to attract end users and enhance their market share

1. Fluid Therapy Market - Overview

  • 1.1. Definitions and Scope

2. Fluid Therapy Market - Executive Summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Fluid Therapy Market - Market Landscape

  • 3.1. Comparative Analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Fluid Therapy Market - Market Forces

  • 4.1. Drivers
  • 4.2. Constraints & Challenges
  • 4.3. Porters five force model
    • 4.3.1. Bargaining power of suppliers
    • 4.3.2. Bargaining powers of customers
    • 4.3.3. Threat of new entrants
    • 4.3.4. Rivalry among existing players
    • 4.3.5. Threat of substitutes

5. Fluid Therapy Market - Strategic Analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product/Market Life Cycle Analysis
  • 5.4. Suppliers and distributors Market Share

6. Fluid Therapy Market - By Therapy

  • 6.1. Introduction
  • 6.2. Human
    • 6.2.1. Maintenance Therapy
    • 6.2.2. Fluid Resuscitation

7. Fluid Therapy Market - By Route of Fluid Administration

  • 7.1. Introduction
  • 7.2. Human
    • 7.2.1. Oral
    • 7.2.2. Subcutaneous
    • 7.2.3. Intravenous
    • 7.2.4. Intraosseous
    • 7.2.5. Others
  • 7.3. Animal
    • 7.3.1. Oral
    • 7.3.2. Subcutaneous
    • 7.3.3. Intraperitoneal
    • 7.3.4. Intravenous
    • 7.3.5. Intraosseous
    • 7.3.6. Others

8. Fluid Therapy Market - By Type of Fluid

  • 8.1. Introduction
  • 8.2. Human
    • 8.2.1. Colloids
    • 8.2.2. Crystalloids
      • 8.2.2.1. Isotonic
      • 8.2.2.2. Hypotonic
      • 8.2.2.3. Hypertonic
    • 8.2.3. Blood & Blood Products
  • 8.3. Animal
    • 8.3.1. Colloids
      • 8.3.1.1. Natural
      • 8.3.1.2. Synthetic
    • 8.3.2. Crystalloids
      • 8.3.2.1. Isotonic
      • 8.3.2.2. Hypotonic
      • 8.3.2.3. Hypertonic

9. Fluid Therapy Market - By Application

  • 9.1. Introduction
  • 9.2. Human
    • 9.2.1. Anesthesia
    • 9.2.2. Cardiopulmonary Resuscitation (CPR)
    • 9.2.3. Congestive Heart Failure (CHF)
    • 9.2.4. Fluids and Transfusions
    • 9.2.5. Hypertonic Saline
    • 9.2.6. Others
  • 9.3. Animal
    • 9.3.1. Anesthesia
    • 9.3.2. Anemia
    • 9.3.3. Diarrhea
    • 9.3.4. Hypovolemia
    • 9.3.5. Cardiac Disease
    • 9.3.6. Others

10. Fluid Therapy Market - By Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Venezuela
    • 10.3.3. Argentina
    • 10.3.4. Ecuador
    • 10.3.5. Peru
    • 10.3.6. Colombia
    • 10.3.7. Costa Rica
    • 10.3.8. Rest of South America
  • 10.4. Europe
    • 10.4.1. France
    • 10.4.2. Denmark
    • 10.4.3. Germany
    • 10.4.4. Spain
    • 10.4.5. Belgium
    • 10.4.6. U.K.
    • 10.4.7. Italy
    • 10.4.8. The Netherlands
    • 10.4.9. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. China
    • 10.5.2. India
    • 10.5.3. Japan
    • 10.5.4. South Korea
    • 10.5.5. Australia & New Zealand
    • 10.5.6. Taiwan
    • 10.5.7. Malaysia
    • 10.5.8. Rest of Asia-Pacific
  • 10.6. Rest of the World
    • 10.6.1. Middle East
    • 10.6.2. Africa

11. Fluid Therapy Market - Market Entropy

  • 11.1. New product launches
  • 11.2. M&A, Collaboration, Partnerships, & JVs

12. Fluid Therapy Market Company Analysis

  • 12.1. Market Share, Company Revenue, Products, M&A, Developments
  • 12.2. Baxter International, Inc. (the U.S.)
  • 12.3. B. Braun Melsungen AG (Germany)
  • 12.4. Fresenius Kabi AG (Germany)
  • 12.5. Dechra Veterinary Products, LLC (the U.S.)
  • 12.6. D.J. Laboratories Pvt. Ltd (India)
  • 12.7. Animalcare Ltd. (the U.K.)
  • 12.8. ICU Medical (the U.S.)
  • 12.9. Company 8
  • 12.10. Company 9
  • 12.11. Company 10 and more

"*Financials would be provided on a best efforts basis for private companies"

13. Fluid Therapy Market -Appendix

  • 13.1. Abbreviations
  • 13.2. Sources